跳至主要内容
临床试验/NL-OMON39831
NL-OMON39831已完成3 期

SYMPATHY: Renal sympathetic denervation as a new treatment for therapy resistant hypertension. - SYMPATHY

niversitair Medisch Centrum Utrecht0 个研究点目标入组 570 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
570

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • 1.Individual has an average 24-hour SBP of >= 130 mmHg or a mean day-time SBP >= 135 mmHg, as determined with the use of ABPM, while the patient uses 3 or more antihypertensive agents or with documented intolerance to 2 or more of the 4 major classes antihypertensive drugs
  • (ACE/ARB, Calcium channel blocker, Beta Blocker, Diuretic) and no possibility to take 3 anti-hypertensive drugs.
  • 2.Individual is >=18 years of age.

排除标准

  • 1.Individual has a treatable secondary cause of hypertension
  • 2.Individual has an eGFR below 1. Individual has a treatable secondary cause of hypertension 3.Individual has renal artery anatomy that is ineligible for treatment

研究者

发起方
niversitair Medisch Centrum Utrecht

相似试验